Auxiliary heterotopic liver transplantation with portal vein arterialization for fulminant hepatic failure.
Auxiliary liver transplantation for patients with fulminant hepatic failure supports the patient's failing liver for a period of time until the native liver (NL) has recovered and immunosuppression can be withdrawn. Auxiliary heterotopic liver transplantation (AHLT) with portal vein arterialization (PVA) has several advantages over auxiliary orthotopic liver transplantation: NL resection is not required, and the hepatic hilum is left untouched; thus, the chances of liver regeneration are optimal. The successful application of emergency AHLT with PVA in a young patient who developed toxic fulminant hepatic failure caused by tuberculostatic drugs is described. Two and one-half months after the procedure, the NL had completely regenerated; the graft was removed, and immunosuppression was suspended.
Margarit
C
C
Department of Surgery, Liver Transplantation Unit, Hospital General Vall Hebrón, Universidad Autónoma Barcelona, Barcelona, Spain. margarit@hg.vhebron.es
Bilbao
I
I
Charco
R
R
Lázaro
J L
JL
Hidalgo
E
E
Allende
E
E
Murio
E
E
D000328:Adult; D000995:Antitubercular Agents / Q000506:poisoning; D001166:Arteriovenous Shunt, Surgical / Q000379:methods; D001706:Biopsy; D006801:Humans; D007083:Iliac Artery / Q000601:surgery*; D017093:Liver Failure / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D008115:Liver Regeneration; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D011169:Portal Vein / Q000601:surgery*; D011877:Radionuclide Imaging; D016042:Transplantation, Heterotopic
D000995:Antitubercular Agents